Skip to main content
. 2015 Jun 25;10(7):1119–1127. doi: 10.2215/CJN.11121114

Table 1.

Patient characteristics by presence of an ICD before propensity match

Factor Patients (n) Non-ICD Group (n=9435) ICD Group (n=1053) P Value
Age (yr) 10,488 72.0±11.7 69.6±11.5 <0.001
Men 10,488 4770 (50.6) 748 (71.0) <0.001
Black race 10,488 1526 (16.2) 173 (16.4) 0.83
BMI (kg/m2) 10,182 29.2±6.6 28.9±5.9 0.21
BMI group (kg/m2) 10,488 <0.001
 <18.5 129 (1.4) 6 (0.57)
 18.5–24.9 2370 (25.1) 282 (26.8)
 25–29.9 3263 (34.6) 368 (34.9)
 ≥30 3372 (35.7) 392 (37.2)
 Missing 301 (3.2) 5 (0.47)
eGFR (ml/min per 1.73 m2) 10,488 44.6±12.0 43.5±11.3 0.004
CKD stage, by eGFR (ml/min per 1.73 m2) 10,488 <0.001
 45–59 5408 (57.3) 532 (50.5)
 30–44 2751 (29.2) 374 (35.5)
 15–29 1081 (11.5) 141 (13.4)
 <15 195 (2.1) 6 (0.57)
Diabetes 10,488 2136 (22.6) 322 (30.6) <0.001
Hypertension 10,488 8041 (85.2) 802 (76.2) <0.001
Congestive heart failure 10,488 1349 (14.3) 698 (66.3) <0.001
Coronary artery disease 10,488 2875 (30.5) 602 (57.2) <0.001
Cerebrovascular disease 10,488 1165 (12.3) 124 (11.8) 0.59
Peripheral vascular disease 10,488 322 (3.4) 54 (5.1) 0.01
Coronary revascularization 10,488 590 (6.3) 181 (17.2) <0.001
Ventricular arrhythmia 10,488 41 (0.43) 72 (6.8) <0.001
Albumin (g/dl) 8967 4.0±0.52 4.1±0.48 0.001
Hemoglobin (g/dl) 9595 12.4±1.9 12.6±1.9 <0.001
Malignancy 10,488 2284 (24.2) 145 (13.8) <0.001
LVEF (%) 10,488 53.6±10.8 24.0±8.3 <0.001
Use of ACEIs/ARBs 10,488 6600 (70.0) 989 (93.9) <0.001
Use of statins 10,488 5790 (61.4) 840 (79.8) <0.001
Use of β-blockers 10,488 6673 (70.7) 996 (94.6) <0.001
Smoking status 10,488 0.72
 No 7670 (81.3) 855 (81.2)
 Yes 591 (6.3) 72 (6.8)
 Missing 1174 (12.4) 126 (12.0)
Insurance group 10,488 0.84
 Private 1671 (17.7) 182 (17.3)
 Medicare/Medicaid 7545 (80.0) 844 (80.2)
 Missing 219 (2.3) 27 (2.6)

Data are given as n (%) or means±SD unless otherwise indicated. ICD, implantable cardioverter-defibrillator; BMI: body mass index; LVEF, left ventricular ejection fraction; ACEI/ARB, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker.